Effects of molgramostim, filgrastim and lenograstim in the treatment of myelokathexis

Pflugers Archiv European Journal of Physiology

Volumn 440, Issue SUPPL. 5, 2000, Pages

  Cernelc, P ^a   Andoljsek, D ^a   Mlakar, U ^a   Pretnar, J ^a   Modic, M ^a   Zupan, I P ^a   Zver, S ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Cytokines; G CSF; GM CSF; Neutropenia; Treatment

Indexed keywords

ANTIBIOTIC AGENT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; FILGRASTIM; LENOGRASTIM; MOLGRAMOSTIM;

ADULT; CASE REPORT; CELL COUNT; CONFERENCE PAPER; DRUG EFFECT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; FEMALE; GRANULOCYTE; HUMAN; MYELOKATHEXIS; NEUTROPENIA; PRIORITY JOURNAL; ANTIBIOTIC THERAPY; ARTICLE; BONE MARROW; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GENETIC DISORDER; LOW BACK PAIN; NEUTROPHIL COUNT; RARE DISEASE; SKIN PRURITUS; SKIN REDNESS; SUFFOCATION;

EID: 0033834749     PISSN: 00316768     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004240000014     Document Type: Conference Paper

References (8)

1. Neutrophil-releasing activity of recombinant human granulocyte-macrophage colony stimulating factor in myelokathexis
2. Myelokathexis treated with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF)
3. Clinical features of myelokathexis and treatment with hematopoietic cytokines: A case report of two patients and review of the literature
4. Chronic idiopathic granulocytopenia
5. Myelokathexis - A congenital form of neutropenia characterized by accelerated apoptosis and defective expression of BCL-X in nutrophil precursors
6. Crossover study of the haematological effects and pharmacokinetics of glycosylated and non-glycosylaled G-CSF in healthy volunteers
7. Clinical and biologic effect of granulocyte colony stimulating factor in the treatment of myelokathexis
8. Myelokathexis - A new form of chronic granulocytopenia report of a case